A new lectin from <i>Amanita vaginata</i> mushroom with potent anti-inflammatory activity


Seliman T. M. H., Ozsoy N., Altıparmak Ülbegi G., Alp-Kavlo H., Arcan G. G., Akev N., ...More

NATURAL PRODUCT RESEARCH, vol.40, no.15, pp.4557-4565, 2026 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 40 Issue: 15
  • Publication Date: 2026
  • Doi Number: 10.1080/14786419.2025.2530212
  • Journal Name: NATURAL PRODUCT RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.4557-4565
  • Keywords: Amanita vaginata, Anti-inflammatory, Chromatography, COX-2, iNOS, Lectin, Mushroom, RAW 264.7 macrophage
  • Istanbul University Affiliated: Yes

Abstract

This study used 80% ammonium sulphate fractional precipitation, followed by affinity chromatography to purify a new lectin (AVL) from the crude extract of the Amanita vaginata mushroom. The purification procedure achieved a 20% yield, a specific activity of 5120 HU/mg protein, and a 16-fold increase in purity. SDS-PAGE analysis showed a single band of 45 kDa. We assessed AVL's anti-inflammatory effect by measuring levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), induced by lipopolysaccharide (LPS), in RAW 264.7 macrophages. Western blot analysis showed that iNOS and COX-2 protein levels were barely detectable in the control groups, but markedly elevated in the LPS-treated groups. However, AVL treatment significantly inhibited the expression of both iNOS and COX-2 in LPS-stimulated cells. This effect was dose-dependent. These findings suggest that AVL's anti-inflammatory effects are mediated through the suppression of iNOS and COX-2 expression.